The global supply of Abacavir Sulfate Active Pharmaceutical Ingredient (API) is handled by a relatively select number of focused manufacturers. Several firms across areas like Europe and the America hold significant shares in this critical segment of the pharmaceutical arena. Quality is of the greatest importance, necessitating stringent regulatory